Degradation of skeletal muscle plasma membrane proteins by calpain.
Observations described here provide the first demonstration that calpain (Ca2+-dependent cysteine protease) can degrade proteins of skeletal muscle plasma membranes. Frog muscle plasma membrane vesicles were incubated with calpain preparations and alterations of protein composition were revealed by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Calpain II (activated by millimolar concentrations of Ca2+) was isolated from frog skeletal muscle, but the activity of calpain I (activated by micromolar concentrations of Ca2+) was lost during attempts at fractionation. Calpain I obtained from skeletal muscle and erythrocytes of rats was tested instead, and exerted effects similar to those of frog muscle calpain on the membrane proteins. All of the calpain preparations caused striking losses of a major membrane protein of molecular mass of approximately 97 kDa, designated band c, and diminution of a thinner band of approximately 200 kDa. There were concomitant increases in 83- and 77-kDa polypeptides. These effects were absolutely dependent on the presence of free Ca2+, and were completely blocked by calpastatin, a specific inhibitor of calpain action. Frog muscle calpain differed only in being relatively more active at 0 degree C than were the calpains from rat tissues. Experimental observations suggest that calpain acts at the cytoplasmic surface of the plasma membrane.
Zaidi
S I
SI
Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201-0509.
Narahara
H T
HT
D000818:Animals; D002154:Calpain / Q000494:pharmacology*; D004910:Erythrocyte Membrane / Q000032:analysis / Q000187:drug effects / Q000378:metabolism; D005260:Female; D008565:Membrane Proteins / Q000032:analysis / Q000378:metabolism*; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D011894:Rana pipiens
D008565:Membrane Proteins; D002154:Calpain